Scenarios that move BDX
Becton, Dickinson and Company Common Stock
Scenarios that move BDX: 15 analyses, 10 positive, 5 negative.
- · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▲ · impact +6 · confidence low · horizon quarters
- · J&J beats Q3 earnings estimates, misses sales and raises outlook — ▲ · impact +15 · confidence low · horizon quarters
- · Viking Therapeutics advances oral obesity drug to Phase III — ▼ · impact -25 · confidence medium · horizon quarters
- · HALO wins court order blocking Merck's European Keytruda SC — ▼ · impact -9 · confidence low · horizon quarters
- · Pacira BioSciences shares skyrocket in today's trading — ▼ · impact -10 · confidence low · horizon quarters
- · BDX expands US manufacturing with $19B healthcare investment — ▲ · impact +80 · confidence high · horizon quarters
- · ◇ What if… Plague outbreak in Russia continues and spreads further — ▲ · impact +28 · confidence low · horizon weeks
- · Zealand Pharma reports positive survodutide Phase III weight loss results — ▲ · impact +29 · confidence medium · horizon quarters
- · Novo Nordisk's Ozempic outperforms Lilly's Mounjaro on cardiovascular risk — ▲ · impact +15 · confidence low · horizon quarters
- · Lilly reports strong weight loss results for new drug — ▲ · impact +28 · confidence low · horizon quarters
- · Kodiak Sciences shares soar 178% on positive wet AMD data — ▲ · impact +8 · confidence low · horizon quarters
- · Beta Bionics stock plunges 37% after safety issues emerge — ▲ · impact +8 · confidence low · horizon quarters
- · Pharma stock soars 150% after injectables deal with Novo — ▲ · impact +40 · confidence medium · horizon quarters
- · ◇ What if… Oral GLP-1 drugs replace injectable treatments — ▼ · impact -58 · confidence high · horizon quarters
- · Eli Lilly Weight Loss Pill Shows Better Results Than Injectable Competitors In Phase 3 Trial — ▼ · confidence medium